In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat

BACKGROUND: In 2022, an outbreak of mpox that started in European countries spread worldwide through human-to-human transmission. Cases have been mostly mild, but severe clinical presentations have been reported. In these cases, tecovirimat has been the drug of choice to treat patients with aggravat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Desiree dos Santos, Higa, Luiza M, Oliveira, Régis Linhares, da Costa, Lendel Correia, Bomfim, Larissa Maciel, Gonçalves, Cássia Cristina Alves, Mariani, Diana, Hruby, Dennis E, Voloch, Carolina Moreira, Castiñeiras, Terezinha Marta Pereira Pinto, Tanuri, Amilcar, Damaso, Clarissa R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337824/
https://www.ncbi.nlm.nih.gov/pubmed/37436275
http://dx.doi.org/10.1590/0074-02760230056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337824/
https://www.ncbi.nlm.nih.gov/pubmed/37436275
http://dx.doi.org/10.1590/0074-02760230056

Ejemplares similares